Evidence map›Paper›PMID 37852641›Full record

Trial reportBMJ (Clinical research ed.)2023

Clinical effectiveness of septoplasty versus medical management for nasal airways obstruction: multicentre, open label, randomised controlled trial.

Sean Carrie, James O'Hara, Tony Fouweather, Tara Homer, Nikki Rousseau, Leila Rooshenas, Alison Bray, Deborah D Stocken, Laura Ternent, Katherine Rennie and 18 more

Registry-linked trialOpen access · hybridAbstract readRandomized Controlled TrialMulticenter Study
In one paragraph

Trial report in BMJ (Clinical research ed.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06731881 (Leveraging Photodynamic Therapy to Inhibit Microorganisms - Assessing the Efficacy of Photodynamic Therapy for Preventing Surgical Site Infections in Nasal Surgery Patients), which is not on this map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
6.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06731881 narecruitingnot on this mapstarted 2025, after this paper: background citation

Leveraging Photodynamic Therapy to Inhibit Microorganisms - Assessing the Efficacy of Photodynamic Therapy for Preventing Surgical Site Infections in Nasal Surgery Patients: A Pilot Study

TypeinterventionalSponsorGuy's and St Thomas' NHS Foundation TrustRan2025 to 2026Enrolled80ConditionsSurgery, Nasal Disease, Light, Therapy, ComplicationsArmsNasal PDT, Photosensitizer formulation only, Standard follow-up, Nasal culture, Flexible nasendoscopy
3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Patient and public involvement and engagement (PPIE) in Otolaryngology research: a systematic review of randomised controlled trials.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2025
    Pooled it
  2. Trial
  3. Exploring the Relationships Between Clinical Examination Findings, Subjective Reported Symptoms and Objective Nasal Patency Measures in Nasal Obstruction: A Baseline NAIROS Sub-Study Analysis.Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery · 2025
    Trial
  4. Article
  5. Article
  6. The effectiveness of nonsurgical nasal devices in relieving nasal obstruction.Annals of the Royal College of Surgeons of England · 2026
    Article
  7. Review
  8. Article
  9. Prevalence and Associated Factors of Olfactory and Gustatory Loss in Patients With Nasal Septal Deviation.Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery · 2026
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

28 authors at 10 institutions in 1 country.

Sean CarrieDepartment of Ear, Nose and Throat, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Freeman Hospital, High Heaton, Newcastle upon Tyne, NE7 7DN, UK sean.carrie@nhs.net.ORCID 0000-0003-1722-1814
James O'HaraDepartment of Ear, Nose and Throat, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Freeman Hospital, High Heaton, Newcastle upon Tyne, NE7 7DN, UK.
Tony FouweatherPopulation Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.
Tara HomerPopulation Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.
Nikki RousseauLeeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.
Leila RooshenasBristol Medical School, Population Health Science Institute, University of Bristol, Bristol, UK.
Alison BrayNorthern Medical Physics and Clinical Engineering, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
Deborah D StockenLeeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.
Laura TernentPopulation Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.
Katherine RennieNewcastle Clinical Trials Unit, Newcastle University, Newcastle upon Tyne, UK.
Emma ClarkNewcastle Clinical Trials Unit, Newcastle University, Newcastle upon Tyne, UK.
Nichola WaughNewcastle Clinical Trials Unit, Newcastle University, Newcastle upon Tyne, UK.
Alison J SteelNewcastle Clinical Trials Unit, Newcastle University, Newcastle upon Tyne, UK.
Jemima DooleyCentre for Academic Primary Care, University of Bristol, Bristol, UK.
Michael DrinnanNorthern Medical Physics and Clinical Engineering, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
David HamiltonPopulation Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.
Kelly LloydLeeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.
Yemi OluboyedePopulation Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.
Caroline WilsonNorthern Ireland Clinical Trials, Belfast, Northern Ireland, UK.
Quentin GardinerDepartment of Ear, Nose and Throat, NHS Tayside, Dundee, UK.
Naveed KaraDepartment of Ear, Nose and Throat, County Durham and Darlington NHS Foundation Trust, Durham, UK.
Sadie KhwajaDepartment of Ear, Nose and Throat, Manchester University Foundation NHS Trust, Manchester, UK.
Samuel C LeongDepartment of Ear, Nose and Throat, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.
Sangeeta MainiDepartment of Ear, Nose and Throat, NHS Grampian, Aberdeen, UK.
Jillian MorrisonGeneral Practice and primary Care, University of Glasgow, Glasgow, UK.
Paul NixDepartment of Ear, Nose and Throat, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
Janet A WilsonPopulation Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.
M Dawn TearePopulation Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.
Newcastle University · GBNewcastle upon Tyne Hospitals NHS Foundation Trust · GBUniversity of Leeds · GBUniversity of Bristol · GBCounty Durham and Darlington NHS Foundation Trust · GBLeeds Teaching Hospitals NHS Trust · GBManchester University NHS Foundation Trust · GBNHS Grampian · GBNHS Tayside · GBUniversity of Glasgow · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo assess the clinical effectiveness of septoplasty.

designMulticentre, randomised controlled trial.

setting17 otolaryngology clinics in the UK's National Health Service.

participants378 adults (≥18 years, 67% men) newly referred with symptoms of nasal obstruction associated with septal deviation and at least moderate symptoms of nasal obstruction (score >30 on the Nasal Obstruction and Symptom Evaluation (NOSE) scale).

interventionsParticipants were randomised 1:1 to receive either septoplasty (n=188) or defined medical management (n=190, nasal steroid and saline spray for six months), stratified by baseline symptom severity and sex.

main outcome measuresThe primary outcome measure was patient reported score on the Sino-Nasal Outcome Test-22 (SNOT-22) at six months, with 9 points defined as the minimal clinically important difference. Secondary outcomes included quality of life and objective nasal airflow measures.

resultsMean SNOT-22 scores at six months were 19.9 (95% confidence interval 17.0 to 22.7) in the septoplasty arm (n=152, intention-to-treat population) and 39.5 (36.1 to 42.9) in the medical management arm (n=155); an estimated 20.0 points lower (better) for participants randomised to receive septoplasty (95% confidence interval 16.4 to 23.6, P<0.001, adjusted for baseline continuous SNOT-22 score and the stratification variables sex and baseline NOSE severity categories). Greater improvement in SNOT-22 scores was predicted by higher baseline symptom severity scores. Quality of life outcomes and nasal airflow measures (including peak nasal inspiratory flow and absolute inhalational nasal partitioning ratio) improved more in participants in the septoplasty group. Readmission to hospital with bleeding after septoplasty occurred in seven participants (4% of 174 who had septoplasty), and a further 20 participants (12%) required antibiotics for infections.

conclusionsSeptoplasty is a more effective intervention than a defined medical management regimen with a nasal steroid and saline spray in adults with nasal obstruction associated with a deviated nasal septum.

trial registrationISRCTN Registry ISRCTN16168569.

Indexed as

Nasal ObstructionAdultFemaleHumansMaleNasal SeptumQuality of LifeState MedicineSteroidsTreatment OutcomeSteroids

Identifiers

PMID37852641
PMCPMC10583133
OpenAlexW4387732581

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.